Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING: a master regulator in the cancer-immunity cycle
Yuanyuan Zhu, Xiang An, Xiao Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Trial watch: STING agonists in cancer therapy
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 221
Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 219
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Juyan Zheng, Junluan Mo, Tao Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 206
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Yanyun Jiang, Lam C. Tsoi, Allison C. Billi, et al.
JCI Insight (2020) Vol. 5, Iss. 20
Open Access | Times Cited: 204
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 203
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
Minlin Jiang, Keyi Jia, Lei Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 2983-2994
Open Access | Times Cited: 202
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 178
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
Erika J. Lampert, Alexandra S. Zimmer, Michelle R. Padget, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 16, pp. 4268-4279
Open Access | Times Cited: 167
Exploring the next generation of antibody–drug conjugates
Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 203-223
Open Access | Times Cited: 159
Exosomes as mediators of immune regulation and immunotherapy in cancer
Fernanda G. Kugeratski, Raghu Kalluri
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 10-35
Open Access | Times Cited: 153
A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
Xuan Wang, Yingqi Liu, Chencheng Xue, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 138
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald J. Fecek, Jennifer L. Taylor, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e001906-e001906
Open Access | Times Cited: 112
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang, Aida Rashidi, Junfei Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses
Isabelle K. Vila, Hanane Chamma, Alizée Steer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 125-139.e8
Open Access | Times Cited: 106
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin
Advanced Materials (2022) Vol. 35, Iss. 21
Open Access | Times Cited: 84
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 158-167
Open Access | Times Cited: 83
Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment
Huanhuan Fan, Zijian Guo
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215027-215027
Closed Access | Times Cited: 53
Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders
Yige Huang, Bangyan Liu, Subhash C. Sinha, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 46
Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 45
Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity
Wen Ma, Rui Sun, Longguang Tang, et al.
Advanced Materials (2023) Vol. 35, Iss. 48
Closed Access | Times Cited: 44
Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
Xianbo Wu, Yuqing Li, Mei Wen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 5, pp. 2643-2692
Closed Access | Times Cited: 33
A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance
Yi Lei, Xin Jiang, Zaigang Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 25
NAMPT‐Driven M2 Polarization of Tumor‐Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer
Sun Mi Hong, A‐Yeon Lee, Byeong‐Ju Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 16
The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications
Daoqi Zhu, Siying Zeng, Chao Su, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top